Related content

A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma

By Park Byeong-Bae   Park Joon   Lee Hyo   Lee Jeeyun   Choi Dong   Choi Seong-Ho   Heo Jin   Lee Jong   Lee Kyu   Lim Do   Park Young   Lim Ho-Yeong   Kang Won   Park Keunchil  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 489-494

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE Junction

By Malik Imtiaz   Bernal Pedro   Byrd Janet  

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 833-838

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

By Song Hong   Do Young   Chang Heung   Ryu Min   Lee Kyung   Kim Yeul   Hong Dae   Cho Jae   Lee Kyoung   Kim Si  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 763-768

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1171-1177

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospective Evaluation of Laparoscopic Celiac Plexus Block in Patients with Unresectable Pancreatic Adenocarcinoma

By Allen Peter  

Annals of Surgical Oncology, Vol. 18, Iss. 3, 2011-03 ,pp. : 636-641

Springer Publishing Company

Access to resources Recommend Favorite